Drug Manufacturers - General · NYSE
Preço Atual
$111.58
MOAT COMPETITIVO
↑Strong Patent Protection on Key Drugs
Merck benefits from patents protecting drugs like Keytruda, creating pricing power and market exclusivity. This shields them from immediate generic competition, driving revenue.
↑Established Brand Reputation and Trust
Decades of research and development have built a strong brand. Doctors and patients trust Merck's products, leading to brand loyalty and market share.
↑Extensive Global Distribution Network
Merck's global reach allows efficient drug distribution. This infrastructure provides a competitive advantage, especially in emerging markets.
RISCOS DE INVESTIMENTO
↓Patent Expirations and Generic Competition
Loss of exclusivity on key drugs will significantly impact revenue. Generic versions erode market share and pricing power quickly.
↓R&D Pipeline Uncertainty and Failure
Drug development is inherently risky, with high failure rates. A lack of successful new drugs could hinder future growth and profitability.
↓Increasing Regulatory Scrutiny and Litigation
Pharmaceutical companies face intense regulatory oversight. Lawsuits and compliance issues can lead to significant financial penalties.
Combine insights de IA com valuation DCF ou PE para calcular o valor intrínseco. Tome decisões melhores baseadas em dados.
Esta página fornece insights de valuation com IA para Merck & Co., Inc. (MRK), incluindo moat competitivo e fatores de risco de investimento. O valuation é central para decisões de investimento sólidas — use as ferramentas de valuation DCF e PE do MiniValuator junto com estes insights de IA para calcular o valor intrínseco de MRK, margem de segurança, e chegar a um valuation bem fundamentado.
